- Home
- SONN vs SPRC Comparison
SONN vs SPRC Comparison
Compare SONN & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- SPRC
- Stock Information
- Founded
- SONN N/A
- SPRC 2004
- Country
- SONN United States
- SPRC Israel
- Employees
- SONN N/A
- SPRC N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- SONN Health Care
- SPRC Health Care
- Exchange
- SONN Nasdaq
- SPRC Nasdaq
- Market Cap
- SONN 3.8M
- SPRC 3.4M
- IPO Year
- SONN N/A
- SPRC N/A
- Fundamental
- Price
- SONN $1.17
- SPRC $0.31
- Analyst Decision
- SONN Strong Buy
- SPRC
- Analyst Count
- SONN 1
- SPRC 0
- Target Price
- SONN $20.00
- SPRC N/A
- AVG Volume (30 Days)
- SONN 35.4K
- SPRC 6.0M
- Earning Date
- SONN 05-13-2025
- SPRC 02-15-2025
- Dividend Yield
- SONN N/A
- SPRC N/A
- EPS Growth
- SONN N/A
- SPRC N/A
- EPS
- SONN N/A
- SPRC N/A
- Revenue
- SONN $1,000,000.00
- SPRC $1,306,000.00
- Revenue This Year
- SONN $5,376.22
- SPRC N/A
- Revenue Next Year
- SONN N/A
- SPRC N/A
- P/E Ratio
- SONN N/A
- SPRC N/A
- Revenue Growth
- SONN 978.39
- SPRC N/A
- 52 Week Low
- SONN $1.08
- SPRC $0.20
- 52 Week High
- SONN $16.00
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- SONN 41.48
- SPRC 50.56
- Support Level
- SONN $1.08
- SPRC $0.27
- Resistance Level
- SONN $1.21
- SPRC $0.32
- Average True Range (ATR)
- SONN 0.08
- SPRC 0.03
- MACD
- SONN -0.01
- SPRC -0.00
- Stochastic Oscillator
- SONN 30.00
- SPRC 40.58
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.